Insider Activity of VIKING GLOBAL INVESTORS LP
Biography of VIKING GLOBAL INVESTORS LP
No biography is available at this moment.
No biography is available at this moment.
| 2025-10-07 | Sale | Inhibrx Biosciences, Inc. INBX | 10 percent owner | 350,000 2.3261% | $32.25 | $11.29M | +149.73% | |
| 2025-06-27 | Sale | BridgeBio Pharma, Inc. BBIO | 10 percent owner | 3.5M 1.8079% | $44.00 | $154M | +50.13% | |
| 2025-01-31 | Sale | BridgeBio Pharma, Inc. BBIO | 10 percent owner | 3.07M 1.5739% | $34.90 | $106.99M | +37.93% | |
| 2024-06-17 | Sale | APi Group Corporation APG | 10 percent owner | 39,032 0.0143% | $38.15 | $1.49M | -3.76% | |
| 2024-03-05 | Sale | APi Group Corporation APG | 10 percent owner | 3.04M 1.0979% | $34.25 | $104.07M | -3.12% | |
| 2024-01-04 | Sale | 4D Molecular Therapeutics, Inc. FDMT | 10 percent owner | 540,000 1.2278% | $19.53 | $10.55M | -9.23% | |
| 2024-01-02 | Sale | APi Group Corporation APG | 10 percent owner | 6.5M 2.6232% | $31.30 | $203.45M | +10.36% | |
| 2023-08-28 | Inhibrx, Inc. INBX | 10 percent owner | 511,627 1.13% | $19.35 | $9.9M | +15.05% | ||
| 2023-07-18 | Sale | BridgeBio Pharma, Inc. BBIO | 10 percent owner | 1.5M 1.0576% | $35.00 | $52.5M | -11.13% | |
| 2023-06-22 | Sale | Roivant Sciences Ltd. ROIV | 10 percent owner | 13M 1.8097% | $9.90 | $128.7M | +8.43% | |
| 2023-05-09 | 4D Molecular Therapeutics, Inc. FDMT | 10 percent owner | 850,000 2.3982% | $16.00 | $13.6M | +4.36% | ||
| 2022-01-11 | Amylyx Pharmaceuticals, Inc. AMLX | 2.3M 11.5074% | $19.00 | $43.7M | +23.75% | |||
| 2021-09-17 | PROCEPT BioRobotics Corporation PRCT | 10 percent owner | 400,000 3.0225% | $35.00 | $14M | -10.97% | ||
| 2021-09-03 | Sale | FIGS, Inc. FIGS | 10 percent owner | 84,826 0.0531% | $44.92 | $3.81M | -54.58% | |
| 2021-09-02 | Sale | FIGS, Inc. FIGS | 10 percent owner | 315,174 0.2036% | $47.28 | $14.9M | -55.36% | |
| 2021-07-29 | Rallybio Corporation RLYB | 10 percent owner | 806,000 2.6995% | $13.00 | $10.48M | -22.23% | ||
| 2020-12-15 | 4D Molecular Therapeutics, Inc. FDMT | 10 percent owner | 2.2M 4.7935% | $23.00 | $50.6M | -22.23% | ||
| 2020-12-14 | Sale | Adaptive Biotechnologies Corporation ADPT | 10 percent owner | 1M 6.3483% | $55.65 | $55.65M | -33.77% | |
| 2020-12-01 | Sale | Zentalis Pharmaceuticals, Inc. ZNTL | 10 percent owner | 500,000 1.7356% | $50.50 | $25.25M | +2.62% | |
| 2020-08-26 | Inhibrx, Inc. INBX | 10 percent owner | 180,219 0.6943% | $18.92 | $3.41M | +32.72% |